Mechanisms of Disease: Apoptosis in heart failure - Seeing hope in death

Nature Clinical Practice Cardiovascular Medicine

Volumn 3, Issue 12, 2006, Pages 681-688

  Narula, Jagat ^a   Haider, Nezam ^a   Arbustini, Eloisa ^b   Chandrashekhar, Y ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CONTRACTILE PROTEIN; CYTOCHROME C; CYTOPLASM PROTEIN;

APOPTOSIS; CELL DEATH; DISEASE COURSE; ENZYME ACTIVATION; FRAGMENTATION REACTION; HEART FAILURE; HEART MUSCLE CELL; HUMAN; INFLAMMATION; MITOCHONDRION; MORTALITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEPLETION; REVIEW;

ANIMALS; APOPTOSIS; CARDIAC OUTPUT, LOW; CASPASES; CYTOCHROMES C; ENERGY METABOLISM; ENZYME ACTIVATION; HUMANS; MITOCHONDRIA, HEART; MYOCARDIAL CONTRACTION; MYOCARDIUM; PROTEASE INHIBITORS; VENTRICULAR REMODELING;

EID: 33751353758     PISSN: 17434297     EISSN: 17434300     Source Type: Journal    
DOI: 10.1038/ncpcardio0710     Document Type: Review

References (43)

1. Thom T et al. (2006) Heart disease and stroke statistics - Update 2006: a report from the American Heart Association Statistics Committee and Stroke statistics subcommittee. Circulation 113: E85-e151
2. Narula J and Young JB (2005) Pathogenesis of heart failure: The penultimate survival instinct. Heart Failure Clinics 1: Xi-xii
3. Massie BM and Conway M (1987) Survival of patients with congestive heart failure: Past, present, and future prospects. Circulation 7: IV11-IV19.
4. Gerdes AM and Capasso JM (1995) Structural remodeling and mechanical dysfunction of cardiac myocytes in heart failure. J Mol Cell Cardiol 27: 849-856
5. Francis GS and McDonald KM (1992) Left ventricular hypertrophy: An initial response to myocardial injury. Am J Cardiol 69:3G-7G
6. Beltrami CA et al. (1995) The cellular basis of dilated cardiomyopathy in humans. J Mol Cell Cardiol 27: 291-305
7. Pouleur HG et al. (1993) Changes in ventricular volume, wall thickness and wall stress during progression of left ventricular dysfunction. The SOLVD Investigators. J Am Coll Cardiol 22 (Suppl A): S43A-S48A
8. Chandrashekhar Y and Narula J (2003) Death hath a thousand doors to let out life. Circ Res 92: 710-714
9. Narula J et al. (1996) Apoptosis in myocytes in endstage heart failure. N Engl J Med 335: 1182-1189
10. Narula J et al. (1999) Apoptosis in heart failure: Release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc Natl Acad Sci USA 96:8144-8149
11. Wencker D et al. (2003) A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest 111: 1497-1504
12. Hayakawa K et al. (2003) Inhibition of granulation tissue cell apoptosis during the subacute stage of myocardial infarction improves cardiac remodeling and dysfunction at the chronic stage. Circulation 108: 104-109
13. Chandrashekhar Y et al. (2004) Long-term caspase inhibition ameliorates apoptosis, reduces myocardial troponin-I cleavage, protects left ventricular function, and attenuates remodeling in rats with myocardial infarction. J Am Coll Cardiol 43: 295-301
14. Katz AM (1994) The cardiomyopathy of overload: An unnatural growth response in the hypertrophied heart. Ann Intern Med 121: 363-371
15. Francis GS and Carlyle WC (1993) Hypothetical pathways of cardiac myocyte hypertrophy: Response to myocardial injury. Eur Heart J 14 (Suppl J): S49-S56
16. Ertl G et al. (1993) Ventricular remodeling after myocardial infarction: experimental and clinical studies. Basic Res Cardiol 88 (Suppl 1): S125-S137
17. Agah R et al. (1997) Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo. J Clin Invest 100: 2722-2728
18. Li Z et al. (1997) Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat. Am J Physiol 272: H2313-H2319
19. Teiger E et al. (1997) Apoptosis in pressure overload induced heart hypertrophy in the rat. J Clin Invest 97: 2891-2897
20. Chang W et al. (1996) Programmed myocyte cell death affects the viable myocardium after infarction in rats. Exp Cell Res 226: 316-327
21. Garg S et al. (2005) Apoptosis and heart failure: Clinical relevance and therapeutic target. J Mol Cell Cardiol 38: 73-79
22. Olivetti G et al. (1997) Apoptosis in the failing human heart. N Eng J Med 336: 1131-1141
23. Reed JC and Paternostro G (1999) Postmitochondrial regulation of apoptosis during heart failure. Proc Natl Acad Sci USA 96: 7614-7616
24. Narula J et al. (2001) Apoptosis and the systolic dysfunction in congestive heart failure: Story of apoptosis interruptus and Zombie myocytes. Cardiol Clin 19: 113-126
25. Haider N et al. (2002) Apoptosis in heart failure represents programmed cell survival, not death, of cardiomyocytes and likelihood of reverse remodeling. J Card Fail 8 (Suppl): S512-S517
26. Kanoh M et al. (1999) Significance of myocytes with DNA in situ nick-end labeling (TUNEL) in hearts with dilated cardiomyopathy: Not apoptosis but DNA repair. Circulation 99: 2757-2764
27. Morissette MR and Rosenzweig A (2005) Targeting survival signaling in heart failure. Curr Opin Pharmacol 5: 165-170
28. Narula N et al. (2005) Is the myofibrillarlytic myocyte a forme fruste apoptotic myocyte? Ann Thorac Surg 79: 1333-1337
29. Communal C et al. (2002) Functional consequences of caspase activation in cardiac myocytes. Proc Natl Acad Sci USA 99: 6252-6256
30. Leist M et al. (1997) Intracellular adenosine triphosphate (ATP) concentration: A switch in the decision between apoptosis and necrosis. J Exp Med 185: 1481-1486
31. Grazette LP et al. (2004) Inhibition of ErbB2 causes mitochondrial dysfunction in cardio-myocytes. Implications for herceptin-induced cardiomyopathy. J Am Coll Cardiol 44: 2231-2238
32. Crone SA et al. (2002) ErbB2 is essential in the prevention of dilated cardiomyopathy. Nat Med 8: 459-465
33. Matsui T et al. (2001) Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation 104:330-335
34. Bartling B et al. (1999) Myocardial gene expression of regulators of myocyte apoptosis and myocyte calcium homeostasis during hemodynamic unloading by ventricular assist devices in patients with end-stage heart failure. Circulation 100: 216-223
35. Milting H et al. (1999) Altered levels of NRNA of apoptosis-mediating genes after mid-term mechanical ventricular support in dilated cardiomyopathy - first results of the Halle Assist Induced Recovery Study (HAIR). Thorac Cardiovasc Surg 47: 48-50
36. Arbustini E et al. (2001) Apoptosis in heart failure: Abrogation of cytochrome c release after ventricular unloading by LVAD [abstract]. Med Pathol 14:43A
37. Adams JW et al. (1998) Enhanced Gaq signaling: A common pathway mediates cardiac hypertrophy and apoptotic heart failure. Proc Natl Acad Sci USA 95: 10140-10145
38. Boersma HH et al. (2005) Past, present, and future of annexin A5: From protein discovery to clinical applications. J Nucl Med 46:2035-2050
39. Yamamoto S et al. (2003) Activation of Mst 1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy. J Clin Invest 111: 1463-1474
40. Hirota H et al. (1999) Loss of a gp 130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell 97: 189-198
41. Yarbrough WM et al. (2003) Pharmacologic inhibition of intracellular caspases after myocardial infarction attenuates left ventricular remodeling: A potentially novel pathway. J Thorac Cardiovasc Surg 125: 1892-1899
42. Goussev A et al. (1998) Effects of ACE inhibition on cardiomyocyte apoptosis in dogs with heart failure. Am J Physiol 275: H626-H631
43. Sabbah HN et al. (2000) Chronic therapy with metoprolol attenuates cardiomyocyte apoptosis in dogs with heart failure. J Am Coll Cardiol 36: 1698-1705